Skip to content
Mitochondrial Support

PQQ (Pyrroloquinoline Quinone)

A redox cofactor and potent antioxidant that uniquely stimulates mitochondrial biogenesis - the growth of new mitochondria. Works synergistically with NMN to comprehensively support cellular energy production. Where NMN improves existing mitochondria, PQQ creates new ones.

energylongevitycognitioncellular-repair
Tier A— Well-tolerated — strong human evidence
Evidence gradeB — Controlled trials / Cohort studies
BH

Editorially reviewed by

BiohackingHub Research Team

Editorial Team · Last updated: October 3, 2026

Mechanism of Action

PQQ (Pyrroloquinoline Quinone) is unique among available supplements for its ability to stimulate mitochondrial biogenesis -- the creation of entirely new mitochondria within cells.

Key mechanisms:

  • PGC-1alpha activation -- PQQ activates the master regulator of mitochondrial biogenesis, driving the creation of new mitochondria rather than merely improving existing ones
  • CREB pathway modulation -- activates the cAMP response element-binding protein, influencing gene expression for energy metabolism
  • Redox cycling -- PQQ can cycle between oxidised and reduced forms thousands of times, making it an exceptionally efficient antioxidant catalyst
  • Neuroprotection -- protects neurons from oxidative damage with particular relevance to age-related neurodegenerative processes

Why PQQ + NMN Is the Complete Mitochondrial Stack

NMNPQQ
Primary targetNAD+ restorationMitochondrial biogenesis
EffectImproves existing mitochondriaCreates new mitochondria
PathwayNAD+/SIRT1PGC-1alpha/CREB

Taking both addresses both the quality (NMN) and quantity (PQQ) of mitochondria simultaneously.

What the Human Trials Show

Three randomised, placebo-controlled trials are worth knowing, and they point in different directions.

Exercise and biogenesis. Twenty-three untrained men took 20 mg/day or placebo during six weeks of supervised endurance training. PGC-1α protein rose significantly more on PQQ. Aerobic performance and body composition did not differ between groups — both improved from the training. PQQ moved a marker of mitochondrial biogenesis without moving a performance outcome over six weeks.

Cognition in older adults. Sixty-four healthy adults aged 40 to under 80 took 21.5 mg/day or placebo for 12 weeks; 58 completed. Composite and verbal memory, reaction time, complex attention, cognitive flexibility and executive function improved versus placebo, with no adverse events reported.

Cognition across ages. A 12-week trial of 20 mg/day in adults aged 20–65 found improvements in composite and verbal memory, with younger adults showing changes in cognitive flexibility and processing speed by week 8.

The honest summary: the cognitive signal is more consistent than the exercise one. For mitochondrial performance PQQ is an optional layer, which is how it is used in the Mito-Peptide Advanced protocol.

Related Research

Stacking Interactions

How PQQ (Pyrroloquinoline Quinone) interacts with other compounds

+
NMNSynergisticweak evidence

The Advanced Mitochondrial Stack. Take PQQ morning alongside NMN.

+
ResveratrolSynergisticweak evidence

Resveratrol activates SIRT1 which feeds into PGC-1alpha - the same pathway PQQ stimulates. Additive effect on mitochondrial biogenesis.

Protocols using PQQ (Pyrroloquinoline Quinone)

Evidence-graded stacks that include this compound

Safety Profile — Tier A

Well-tolerated — strong human evidence

Contraindications

  • ●No established absolute contraindications at standard doses

Side Effects

  • ●Headache at doses above 40mg (uncommon)
  • ●Mild fatigue in early days of supplementation
  • ●Rare: mild gastrointestinal discomfort

Drug Interactions

No significant established interactions